Product NDC: | 0002-7511 |
Proprietary Name: | Humalog |
Non Proprietary Name: | Insulin lispro |
Active Ingredient(s): | 100 [iU]/mL & nbsp; Insulin lispro |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-7511 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021017 |
Marketing Category: | NDA |
Start Marketing Date: | 19991222 |
Package NDC: | 0002-7511-99 |
Package Description: | 1 VIAL in 1 CARTON (0002-7511-99) > 10 mL in 1 VIAL |
NDC Code | 0002-7511-99 |
Proprietary Name | Humalog |
Package Description | 1 VIAL in 1 CARTON (0002-7511-99) > 10 mL in 1 VIAL |
Product NDC | 0002-7511 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Insulin lispro |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 19991222 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | INSULIN LISPRO |
Strength Number | 100 |
Strength Unit | [iU]/mL |
Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |